1
|
Carpentier S, Aldon D, Berthomé R, Galaud JP. Is there a specific calcium signal out there to decode combined biotic stress and temperature elevation? Front Plant Sci 2022; 13:1004406. [PMID: 36407594 PMCID: PMC9669060 DOI: 10.3389/fpls.2022.1004406] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Grants] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 07/27/2022] [Accepted: 10/20/2022] [Indexed: 06/16/2023]
Affiliation(s)
- Sarah Carpentier
- Laboratoire de Recherche en Sciences Végétales, Université de Toulouse, CNRS, UPS, Toulouse, France
- Laboratoire de Recherche en Sciences Végétales, Université de Toulouse, CNRS, UPS, Toulouse INP, Auzeville-Tolosane, France
| | - Didier Aldon
- Laboratoire de Recherche en Sciences Végétales, Université de Toulouse, CNRS, UPS, Toulouse, France
| | - Richard Berthomé
- Laboratoire de Recherche en Sciences Végétales, Université de Toulouse, CNRS, UPS, Toulouse INP, Auzeville-Tolosane, France
| | - Jean-Philippe Galaud
- Laboratoire de Recherche en Sciences Végétales, Université de Toulouse, CNRS, UPS, Toulouse, France
| |
Collapse
|
2
|
masri AA, Carpentier S, Leroy F, battini S, Julien T, Maaloul F. 54 Skin-dose mapping for patients undergoing interventional radiology procedures: Clinical experimentations versus a Dose Archiving and Communication System. Phys Med 2019. [DOI: 10.1016/j.ejmp.2019.09.135] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
3
|
Guérin L, Carpentier S, Leroy F, Maaloul F. 54 Development of a model for predicting radiological risks in interventional cardiology. Phys Med 2018. [DOI: 10.1016/j.ejmp.2018.09.067] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/01/2022] Open
|
4
|
Julien T, Carpentier S, Guérin L, Battini S, Maaloul F. 38 Feedback on the use of a DACS for five years in interventional cardiology. Phys Med 2018. [DOI: 10.1016/j.ejmp.2018.09.120] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/27/2022] Open
|
5
|
Masri AA, Aktaou S, Carpentier S, Leroy F, Maaloul F. 41A Influence of radiation protection equipment on the operator and patient dosimetry in coronary angiography. Phys Med 2018. [DOI: 10.1016/j.ejmp.2018.09.126] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
|
6
|
Carpentier S, van Gastel J, Schoenaers J, Carels C, Vander Poorten V, Coucke W, Verdonck A. Evaluation of transverse maxillary expansion after a segmental posterior subapical maxillary osteotomy in cleft lip and palate patients with severe collapse of the lateral maxillary segments. Cleft Palate Craniofac J 2018; 51:651-7. [PMID: 25368909 DOI: 10.1597/113-232] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
Abstract
Objective : The purpose of this longitudinal retrospective study was to evaluate transverse maxillary expansion after a Schuchardt or segmental posterior subapical maxillary osteotomy (SPSMO) in patients with cleft lip and palate (CLP). A second aim was to compare these data with data for adult patients without CLP who were receiving a surgical assisted rapid palatal expansion (SARPE). Method : The study group comprised 19 patients with CLP and a severe transversally collapsed maxilla who were treated with SPSMO followed by hyrax expansion at the University Hospitals Leuven. Dental casts of the 19 patients were analyzed before treatment, at maximum expansion, during orthodontic treatment, at the completion of orthodontic treatment. and 2 years after orthodontic treatment and were measured at the canine, premolar, and molar levels. Adult patients without CLP who were enrolled in a prospective study served as the control group. Results : Maxillary expansion within the study group was significantly greater (P < .05) at all measured levels compared with the maxillary arch before treatment. No significant relapse was measured in the study group 2 years after orthodontic treatment. When comparing the study and control groups, the only statistical difference was that canine expansion was significantly greater in the study group. Conclusion : SPSMO followed by maxillary expansion and orthodontic treatment is an appropriate treatment option to correct a severe transversally collapsed maxilla in patients with CLP. The overall treatment effect of SPSMO expansion is comparable with the effects of SARPE, although canine expansion was greater in the SPSMO group.
Collapse
|
7
|
Ansite J, Balamurugan AN, Barbaro B, Battle J, Brandhorst D, Cano J, Chen X, Deng S, Feddersen D, Friberg A, Gilmore T, Goldstein JS, Holbrook E, Khan A, Kin T, Lei J, Linetsky E, Liu C, Luo X, McElvaney K, Min Z, Moreno J, O'Gorman D, Papas KK, Putz G, Ricordi C, Szot G, Templeton T, Wang L, Wilhelm JJ, Willits J, Wilson T, Zhang X, Avila J, Begley B, Cano J, Carpentier S, Holbrook E, Hutchinson J, Larsen CP, Moreno J, Sears M, Turgeon NA, Webster D, Deng S, Lei J, Markmann JF, Bridges ND, Czarniecki CW, Goldstein JS, Putz G, Templeton T, Wilson T, Eggerman TL, Al-Saden P, Battle J, Chen X, Hecyk A, Kissler H, Luo X, Molitch M, Monson N, Stuart E, Wallia A, Wang L, Wang S, Zhang X, Bigam D, Campbell P, Dinyari P, Kin T, Kneteman N, Lyon J, Malcolm A, O'Gorman D, Onderka C, Owen R, Pawlick R, Richer B, Rosichuk S, Sarman D, Schroeder A, Senior PA, Shapiro AMJ, Toth L, Toth V, Zhai W, Johnson K, McElroy J, Posselt AM, Ramos M, Rojas T, Stock PG, Szot G, Barbaro B, Martellotto J, Oberholzer J, Qi M, Wang Y, Bayman L, Chaloner K, Clarke W, Dillon JS, Diltz C, Doelle GC, Ecklund D, Feddersen D, Foster E, Hunsicker LG, Jasperson C, Lafontant DE, McElvaney K, Neill-Hudson T, Nollen D, Qidwai J, Riss H, Schwieger T, Willits J, Yankey J, Alejandro R, Corrales AC, Faradji R, Froud T, Garcia AA, Herrada E, Ichii H, Inverardi L, Kenyon N, Khan A, Linetsky E, Montelongo J, Peixoto E, Peterson K, Ricordi C, Szust J, Wang X, Abdulla MH, Ansite J, Balamurugan AN, Bellin MD, Brandenburg M, Gilmore T, Harmon JV, Hering BJ, Kandaswamy R, Loganathan G, Mueller K, Papas KK, Pedersen J, Wilhelm JJ, Witson J, Dalton-Bakes C, Fu H, Kamoun M, Kearns J, Li Y, Liu C, Luning-Prak E, Luo Y, Markmann E, Min Z, Naji A, Palanjian M, Rickels M, Shlansky-Goldberg R, Vivek K, Ziaie AS, Fernandez L, Kaufman DB, Zitur L, Brandhorst D, Friberg A, Korsgren O. Purified Human Pancreatic Islets, CIT Culture Media with Lisofylline or Exenatide. CellR4 Repair Replace Regen Reprogram 2017; 5:e2377. [PMID: 30613755 PMCID: PMC6319648] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Grants] [Subscribe] [Scholar Register] [Indexed: 06/09/2023]
|
8
|
Mouttet D, Laé M, Caly M, Gentien D, Carpentier S, Peyro-Saint-Paul H, Vincent-Salomon A, Rouzier R, Sigal-Zafrani B, Sastre-Garau X, Reyal F. Estrogen-Receptor, Progesterone-Receptor and HER2 Status Determination in Invasive Breast Cancer. Concordance between Immuno-Histochemistry and MapQuant™ Microarray Based Assay. PLoS One 2016; 11:e0146474. [PMID: 26829108 PMCID: PMC4735463 DOI: 10.1371/journal.pone.0146474] [Citation(s) in RCA: 28] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/07/2015] [Accepted: 12/17/2015] [Indexed: 11/21/2022] Open
Abstract
Background Hormone receptor status and HER2 status are of critical interest in determining the prognosis of breast cancer patients. Their status is routinely assessed by immunohistochemistry (IHC). However, it is subject to intra-laboratory and inter-laboratory variability. The aim of our study was to compare the estrogen receptor, progesterone receptor and HER2 status as determined by the MapQuant™ test to the routine immuno-histochemical tests in early stage invasive breast cancer in a large comprehensive cancer center. Patients and Methods We retrospectively studied 163 invasive early-stage breast carcinoma with standard IHC status. The genomic status was determined using the MapQuant™ test providing the genomic grade index. Results We found only 4 tumours out of 161 (2.5%) with discrepant IHC and genomic results concerning ER status. The concordance rate between the two methods was 97.5% and the Cohen’s Kappa coefficient was 0.89. Comparison between the MapQuant™ PR status and the PR IHC status gave more discrepancies. The concordance rate between the two methods was 91.4% and the Cohen’s Kappa coefficient was 0.74. The HER2 MapQuant™ test was classified as « undetermined » in 2 out of 163 cases (1.2%). One HER2 IHC-negative tumour was found positive with a high HER2 MapQuant™ genomic score. The concordance rate between the two methods was 99.3% and the Cohen’s Kappa coefficient was 0.86. Conclusion Our results show that the MapQuant™ assay, based on mRNA expression assay, provides an objective and quantitative assessment of Estrogen receptor, Progesterone receptor and HER2 status in invasive breast cancer.
Collapse
Affiliation(s)
- D. Mouttet
- Department of Surgery, Institut Curie, Paris, France
| | - M. Laé
- Department of Tumor Biology, Institut Curie, Paris, France
| | - M. Caly
- Department of Tumor Biology, Institut Curie, Paris, France
| | - D. Gentien
- Department of Translational Research, Institut Curie, Paris, France
| | | | | | | | - R. Rouzier
- Department of Surgery, Institut Curie, Paris, France
| | | | | | - F. Reyal
- Department of Surgery, Institut Curie, Paris, France
- Residual Tumor and Response to Treatment Team, Institut Curie, Department of Translational Research, Paris, France
- * E-mail:
| |
Collapse
|
9
|
Maurice J, Carpentier S, Leroy F, Maaloul F. Overall management of radiological risks in interventional cardiology: Dose prediction, optimization and follow-up. Phys Med 2015. [DOI: 10.1016/j.ejmp.2015.10.063] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/01/2022] Open
|
10
|
Soler L, Miller I, Nöbauer K, Carpentier S, Niewold T. Identification of the major regenerative III protein (RegIII) in the porcine intestinal mucosa as RegIIIγ, not RegIIIα. Vet Immunol Immunopathol 2015; 167:51-6. [PMID: 26187439 DOI: 10.1016/j.vetimm.2015.07.006] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/16/2015] [Revised: 07/01/2015] [Accepted: 07/03/2015] [Indexed: 12/13/2022]
Abstract
During the last years, an antimicrobial protein from the RegIII family has been consistently identified as one of the main up-regulated mRNA transcripts in the pig small intestinal mucosa during different infections such as enterotoxigenic Escherichia coli (ETEC). This transcript has been mainly referred to in the literature as pancreatitis-associated protein (PAP/RegIIIα). However, the identity of this transcript has not been confirmed, and no evidence of its expression at the protein level is available in the literature, because the absence of a specific antibody. In this study, we first unequivocally identified the PAP/RegIII family protein mainly expressed in ETEC infected pig intestine as RegIIIγ by 2D-DIGE and MALDI-TOF/TOF. This shows that the pig differs from species like human and mice in that RegIIIγ (and not RegIIIα) might be the major RegIII isotype during intestinal infection. Immunoblotting analysis with a specifically generated polyclonal rabbit antibody revealed that pig RegIIIγ is expressed throughout the intestinal tract, but most abundantly in the ileum. Although a higher abundance of mRNA was paralleled by higher protein abundance, a lack of linear relationship was found between RegIIIγ mRNA and protein abundances in the jejunal mucosa, the latter most pronounced in the case of natural infection. This may be related to the secretory nature of RegIIIγ. This would mean that the antimicrobial protein RegIIIγ is a good candidate as a non-invasive faecal intestinal health biomarker in swine.
Collapse
Affiliation(s)
- L Soler
- Livestock-Nutrition-Quality Division, Biosystems Department, Faculty of Biosciences Engineering, KU Leuven, Kasteelpark Arenberg 30, Heverlee 3001, Belgium
| | - I Miller
- Department of Biomedical Sciences, University of Veterinary Medicine, Veterinaerplatz 1, 1210 Vienna, Austria
| | - K Nöbauer
- VetCore, University of Veterinary Medicine, Veterinaerplatz 1, 1210 Vienna, Austria
| | - S Carpentier
- Division of Crop Biotechnics, O&N II Herestraat 49 - Box 901, Leuven 3000, Belgium
| | - T Niewold
- Livestock-Nutrition-Quality Division, Biosystems Department, Faculty of Biosciences Engineering, KU Leuven, Kasteelpark Arenberg 30, Heverlee 3001, Belgium.
| |
Collapse
|
11
|
Aernout EM, Carpentier S. [Early prenatal interview knowledge in post-partum women: Cross-sectional study in 2011 in Lille (France)]. ACTA ACUST UNITED AC 2015; 45:337-42. [PMID: 25998179 DOI: 10.1016/j.jgyn.2015.04.013] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/11/2015] [Revised: 03/06/2015] [Accepted: 04/14/2015] [Indexed: 11/20/2022]
Abstract
OBJECTIVES Early prenatal interview (EPI) is one of the flagship measures of the 2005-2007 perinatal strategy. It allows mothers to have a 45-minute interview, distinct from a medical consultation, promoting the expression of their expectations and medical, psychological or social difficulties. It should be routinely offered to all mothers in early pregnancy. The main objective of our study was to determine the proportion of women who had knowledge of Early prenatal interview and to profile women who knew it. Secondary objectives were to describe the EPI achievement rate and its terms of implementation. MATERIALS AND METHODS All women who gave birth between 16 and 20 January 2011 in one of the ten maternity hospitals of the Lille metropolis were interviewed during their stay in maternity. A mixed model logistic regression was made to draw the profile of women with knowledge of Early prenatal interview. RESULTS Of 311 women who gave birth during the study period, 270 were included in the survey. 148 patients (54.8 %) knew Early prenatal interview and 79 (29.3 %) had it. Women who had a high level of education were significantly more aware of this interview than those with low level of study. Other factors studied were not significantly related to knowledge of the EPI. CONCLUSION While the EPI should be routinely offered to all pregnant women, only half of the patients who give birth had heard about it during their pregnancy. Women of low educational level should be more targeted by professional performing this interview.
Collapse
Affiliation(s)
- E M Aernout
- Réseau de santé en périnatalité de Lille Métropole, réseau Ombrel, DGID, université Lille Nord-de-France, hôpital Jeanne-de-Flandres, 1, rue Eugène-Avinée, 59037 Lille cedex, France.
| | - S Carpentier
- Réseau de santé en périnatalité de Lille Métropole, réseau Ombrel, DGID, université Lille Nord-de-France, hôpital Jeanne-de-Flandres, 1, rue Eugène-Avinée, 59037 Lille cedex, France
| |
Collapse
|
12
|
Marx-Deseure A, Carpentier S, Thomas D, Bouquillon S, Delobel B, Bailleux B, Bomy H, Vaast P, Debarge V. [Birth of a child with Down syndrome: parental choice or failure of screening policy?]. Gynecol Obstet Fertil 2015; 43:284-289. [PMID: 25813435 DOI: 10.1016/j.gyobfe.2015.02.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/30/2014] [Accepted: 02/02/2015] [Indexed: 06/04/2023]
Abstract
OBJECTIVES Birth of a child with Down syndrome (DS) can follow parental choice or failure of screening. The objective of this work is to describe the circumstances of births of children with DS in a French perinatal health network. METHODS Retrospective multicentric study, with prospective trial registration of all children born alive with DS, between 2010 and 2013. RESULTS Sixty-three children were born with DS. Complete screening was performed by 61 % of patients, incomplete screening by 29 % of patients and no screening test by 10 %. Among these births, 50 % occurred following parental choice, 40 % following failure of screening and for 10 %, parental choice concerning screening was unknown. False negative had often calculating risk close to 1/1000. CONCLUSION In this study, the birth of a child with DS occurred following parental choice in half of cases. It's necessary, to optimize the follow-up, to document in medical records the medical information and parental choice concerning DS screening and data of screening when this was done.
Collapse
Affiliation(s)
- A Marx-Deseure
- Pôle d'obstétrique, CHRU de Lille, hôpital Jeanne-de-Flandre, avenue Eugène-Avinée, 59037 Lille cedex, France.
| | - S Carpentier
- Réseau de santé en périnatalité OMBREL, CHRU de Lille, hôpital Jeanne-de-Flandre, 59037 Lille cedex, France
| | - D Thomas
- Pôle pédiatrie, CHRU de Lille, hôpital Jeanne-de-Flandre, avenue Eugène-Avinée, 59037 Lille cedex, France
| | - S Bouquillon
- Pôle de biopathologie, laboratoire de cytogénétique, CHRU de Lille, 59037 Lille cedex, France
| | - B Delobel
- Laboratoire de génétique, hôpital Saint-Vincent-de-Paul, 59020 Lille, France
| | - B Bailleux
- Réseau de santé en périnatalité OMBREL, CHRU de Lille, hôpital Jeanne-de-Flandre, 59037 Lille cedex, France
| | - H Bomy
- Réseau de santé en périnatalité OMBREL, CHRU de Lille, hôpital Jeanne-de-Flandre, 59037 Lille cedex, France
| | - P Vaast
- Pôle d'obstétrique, CHRU de Lille, hôpital Jeanne-de-Flandre, avenue Eugène-Avinée, 59037 Lille cedex, France
| | - V Debarge
- Pôle d'obstétrique, CHRU de Lille, hôpital Jeanne-de-Flandre, avenue Eugène-Avinée, 59037 Lille cedex, France; Université de Lille 2, 59000 Nord de France, France
| |
Collapse
|
13
|
Janiak M, Kissel E, Van Dijck P, Carpentier S. THE UNKNOWN SHADOWS OF TREHALASE. Commun Agric Appl Biol Sci 2015; 80:71-76. [PMID: 26630758] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
Abstract
Each year brings new facts concerning multiple roles of sugar pathways in plant metabolism. One of them--the trehalose pathway--has been shown to play a role in stress signalling. The last enzyme of this pathway--trehalase--has been proven to be strongly expressed in guard cells. Modifications of its abundance cause changes in stomatal closure and response to abscisic acid. Our phenotypical studies of different mutants of Arabidopsis thaliana and Musa have enabled us to propose a new function of trehalase. It might play a role in the feedback of sucrose as a closing signal for stomata in reaction to an efficient photosynthesis. To characterize the phenotype we measured: the dynamic cumulative water loss, the dynamic leaf surface temperature, and the stomatal conductance. Based on the obtained results we have determined the time points for a proteomics study. The exact role of trehalase and related proteins in the proposed mechanism will be defined with multiple analysis including mass spectrophotometry and enzymatic activities. The samples will be collected from a wide type of plants including model organism (Arabidopsis--wild type, trehalase mutant plants) and crops (banana). The final results will shed light on the complete role of trehalase and the feedback pathway.
Collapse
|
14
|
Carpentier S, Royer B, Maaloul F, Leroy F. Development of a predictive model to reduce the patient radiation dose risk in interventional cardiology. Phys Med 2014. [DOI: 10.1016/j.ejmp.2014.10.025] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/27/2022] Open
|
15
|
Carpentier S, van Gastel J, Schoenaers J, Carels C, Vander Poorten V, Coucke W, Verdonck A. Evaluation of Transverse Maxillary Expansion After a Segmental Posterior Subapical Maxillary Osteotomy in Cleft Lip and Palate Patients With Severe Collapse of the Lateral Maxillary Segments. Cleft Palate Craniofac J 2014:140611123559002. [PMID: 24919125 DOI: 10.1597/13-232] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
Abstract
Objective : The purpose of this longitudinal retrospective study was to evaluate transverse maxillary expansion after a Schuchardt or segmental posterior subapical maxillary osteotomy (SPSMO) in patients with cleft lip and palate (CLP). A second aim was to compare these data with data for adult patients without CLP who were receiving a surgical assisted rapid palatal expansion (SARPE). Method : The study group comprised 19 patients with CLP and a severe transversally collapsed maxilla who were treated with SPSMO followed by hyrax expansion at the University Hospitals Leuven. Dental casts of the 19 patients were analyzed before treatment, at maximum expansion, during orthodontic treatment, at the completion of orthodontic treatment. and 2 years after orthodontic treatment and were measured at the canine, premolar, and molar levels. Adult patients without CLP who were enrolled in a prospective study served as the control group. Results : Maxillary expansion within the study group was significantly greater (P < .05) at all measured levels compared with the maxillary arch before treatment. No significant relapse was measured in the study group 2 years after orthodontic treatment. When comparing the study and control groups, the only statistical difference was that canine expansion was significantly greater in the study group. Conclusion : SPSMO followed by maxillary expansion and orthodontic treatment is an appropriate treatment option to correct a severe transversally collapsed maxilla in patients with CLP. The overall treatment effect of SPSMO expansion is comparable with the effects of SARPE, although canine expansion was greater in the SPSMO group.
Collapse
|
16
|
Carpentier S, Schoenaers J, Carels C, Verdonck A. Cranio-maxillofacial, orthodontic and dental treatment in three patients with Apert syndrome. Eur Arch Paediatr Dent 2014; 15:281-9. [DOI: 10.1007/s40368-013-0105-9] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/26/2013] [Accepted: 12/05/2013] [Indexed: 10/25/2022]
|
17
|
Abstract
Objective To determine whether patients with neuropsychiatric (NP) events attributed to systemic lupus erythematosus (SLE) have more global disease activity than patients with NP events not attributed to SLE. Methods Patients were recruited from an academic lupus clinic. Global disease activity was measured with the SLE Disease Activity Index 2000 (SLEDAI-2K) and organ damage with the Systemic Lupus International Collaborating Clinics (SLICC)/American College of Rheumatology (ACR) damage index (SDI). NP disease was defined using the ACR case definitions and decision rules for attribution of NP events to SLE and non-SLE causes. Results There were 68 patients (age (mean ± SD) 40.8 ± 15.2 years, 85% female, 94% Caucasians) with 126 NP events. SLEDAI-2K scores in patients with NP events attributed to SLE were higher than in patients with NP events attributed to non-SLE causes even when NP variables were removed from the SLEDAI-2K (mean ± SD: SLE NP = 7.36 ± 5.42 vs non-SLE NP = 5.53 ± 4.57, P = 0.042). Patients with CNS and diffuse NP events, rather that PNS and focal events, accounted for the group differences in SLEDAI-2K scores. There were no significant differences in total SDI scores comparing NP events due to SLE vs. non-SLE causes (mean ± SD: 2.1 ± 1.8 vs. 1.7 ± 1.7; p = 0.28) even when NP variables were omitted. Conclusions Increased global SLE disease activity is associated with concurrent NP events attributed to SLE, particularly for diffuse NP and CNS NP events. The findings have diagnostic and therapeutic implications for SLE patients with NP events and inform pathogenetic mechanisms underlying NPSLE.
Collapse
Affiliation(s)
| | | | | | - S Doucette
- Research Methods Unit and Department of Community Health and Epidemiology
| | - JG Hanly
- Division of Rheumatology
- Departments of Medicine and Pathology, Dalhousie University and Queen Elizabeth II Health Sciences Center, Halifax, Nova Scotia, Canada
| |
Collapse
|
18
|
Dyment DA, Sell E, Vanstone MR, Smith AC, Garandeau D, Garcia V, Carpentier S, Le Trionnaire E, Sabourdy F, Beaulieu CL, Schwartzentruber JA, McMillan HJ, Majewski J, Bulman DE, Levade T, Boycott KM. Evidence for clinical, genetic and biochemical variability in spinal muscular atrophy with progressive myoclonic epilepsy. Clin Genet 2013; 86:558-63. [PMID: 24164096 DOI: 10.1111/cge.12307] [Citation(s) in RCA: 30] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/27/2013] [Revised: 10/08/2013] [Accepted: 10/22/2013] [Indexed: 10/26/2022]
Abstract
Spinal muscular atrophy with progressive myoclonic epilepsy (SMA-PME) is a recently delineated, autosomal recessive condition caused by rare mutations in the N-acylsphingosine amidohydrolase 1 (acid ceramidase) ASAH1 gene. It is characterized by motor neuron disease followed by progressive myoclonic seizures and eventual death due to respiratory insufficiency. Here we report an adolescent female who presented with atonic and absence seizures and myoclonic jerks and was later diagnosed as having myoclonic-absence seizures. An extensive genetic and metabolic work-up was unable to arrive at a molecular diagnosis. Whole exome sequencing (WES) identified two rare, deleterious mutations in the ASAH1 gene: c.850G>T;p.Gly284X and c.456A>C;p.Lys152Asn. These mutations were confirmed by Sanger sequencing in the patient and her parents. Functional studies in cultured fibroblasts showed that acid ceramidase was reduced in both overall amount and enzymatic activity. Ceramide level was doubled in the patient's fibroblasts as compared to control cells. The results of the WES and the functional studies prompted an electromyography (EMG) study that showed evidence of motor neuron disease despite only mild proximal muscle weakness. These findings expand the phenotypic spectrum of SMA-PME caused by novel mutations in ASAH1 and highlight the clinical utility of WES for rare, intractable forms of epilepsy.
Collapse
Affiliation(s)
- D A Dyment
- Department of Genetics, Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada; Children's Hospital of Eastern Ontario Research Institute, University of Ottawa, Ottawa, Ontario, Canada
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
19
|
Gnofam M, Muller D, Meriaux M, Carpentier S, Deruelle P. Influence de la pression atmosphérique et de ses variations sur la rupture prématurée des membranes. ACTA ACUST UNITED AC 2013; 42:678-84. [DOI: 10.1016/j.jgyn.2013.01.008] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/04/2012] [Revised: 01/24/2013] [Accepted: 01/30/2013] [Indexed: 11/25/2022]
|
20
|
Adachi JI, Totake K, Shirahata M, Mishima K, Suzuki T, Yanagisawa T, Fukuoka K, Nishikawa R, Arimappamagan A, Manoj N, Mahadevan A, Bhat D, Arvinda H, Indiradevi B, Somanna S, Chandramouli B, Petterson SA, Hermansen SK, Dahlrot RH, Hansen S, Kristensen BW, Carvalho F, Jalali S, Singh S, Croul S, Aldape K, Zadeh G, Choi J, Park SH, Khang SK, Suh YL, Kim SP, Lee YS, Kim SH, Coberly S, Samayoa K, Liu Y, Kiaei P, Hill J, Patterson S, Damore M, Dahiya S, Emnett R, Phillips J, Haydon D, Leonard J, Perry A, Gutmann D, Epari S, Ahmed S, Gurav M, Raikar S, Moiyadi A, Shetty P, Gupta T, Jalali R, Georges J, Zehri A, Carlson E, Martirosyan N, Elhadi A, Nichols J, Ighaffari L, Eschbacher J, Feuerstein B, Anderson T, Preul M, Jensen K, Nakaji P, Girardi H, Monville F, Carpentier S, Giry M, Voss J, Jenkins R, Boisselier B, Frayssinet V, Poggionovo C, Catteau A, Mokhtari K, Sanson M, Peyro-Saint-Paul H, Giannini C, Hide T, Nakamura H, Makino K, Yano S, Anai S, Shinojima N, Kuroda JI, Takezaki T, Kuratsu JI, Higuchi F, Matsuda H, Iwata K, Ueki K, Kim P, Kong J, Cooper L, Wang F, Gao J, Teodoro G, Scarpace L, Mikkelsen T, Schniederjan M, Moreno C, Saltz J, Brat D, Cho U, Hong YK, Lee YS, Lober R, Lu L, Gephart MH, Fisher P, Miyazaki M, Nishihara H, Itoh T, Kato M, Fujimoto S, Kimura T, Tanino M, Tanaka S, Nguyen N, Moes G, Villano JL, Nishihara H, Kanno H, Kato Y, Tanaka S, Ohnishi T, Harada H, Ohue S, Kouno S, Inoue A, Yamashita D, Okamoto S, Nitta M, Muragaki Y, Maruyama T, Sawada T, Komori T, Saito T, Okada Y, Omay SB, Gunel JM, Clark VE, Li J, Omay EZE, Serin A, Kolb LE, Hebert RM, Bilguvar K, Ozduman K, Pamir MN, Kilic T, Baehring J, Piepmeier JM, Brennan CW, Huse J, Gutin PH, Yasuno K, Vortmeyer A, Gunel M, Perry A, Pugh S, Rogers CL, Brachman D, McMillan W, Jenrette J, Barani I, Shrieve D, Sloan A, Mehta M, Prabowo A, Iyer A, Veersema T, Anink J, Meeteren ASV, Spliet W, van Rijen P, Ferrier T, Capper D, Thom M, Aronica E, Chharchhodawala T, Sable M, Sharma MC, Sarkar C, Suri V, Singh M, Santosh V, Thota B, Srividya M, Sravani K, Shwetha S, Arivazhagan A, Thennarasu K, Chandramouli B, Hegde A, Kondaiah P, Somasundaram K, Rao M, Santosh V, Kumar VP, Thota B, Shastry A, Arivazhagan A, Thennarasu K, Kondaiah P, Shastry A, Narayan R, Thota B, Somanna S, Thennarasu K, Arivazhagan A, Santosh V, Shastry A, Naz S, Thota B, Thennarasu K, Arivazhagan A, Somanna S, Santosh V, Kondaiah P, Venneti S, Garimella M, Sullivan L, Martinez D, Huse J, Heguy A, Santi M, Thompson C, Judkins A, Voronovich Z, Chen L, Clark K, Walsh M, Mannas J, Horbinski C, Wiestler B, Capper D, Holland-Letz T, Korshunov A, von Deimling A, Pfister SM, Platten M, Weller M, Wick W, Zieman G, Dardis C, Ashby L, Eschbacher J. PATHOLOGY. Neuro Oncol 2013. [DOI: 10.1093/neuonc/not184] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
21
|
Carpentier S, Ghijselings E, Schoenaers J, Carels C, Verdonck A. Enamel defects on the maxillary premolars in patients with cleft lip and/or palate: a retrospective case-control study. Eur Arch Paediatr Dent 2013; 15:159-65. [PMID: 24101590 DOI: 10.1007/s40368-013-0078-8] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/30/2013] [Accepted: 08/03/2013] [Indexed: 11/24/2022]
Abstract
AIM The purpose of this study was to investigate the presence of developmental defects of enamel on maxillary premolars in patients with cleft lip and/or palate. In addition, the relationship with the surgical technique of soft palate closure was studied. Such a relationship could be suspected since formation of enamel occurs around the same time period as soft palate closure. MATERIALS AND METHODS The study consisted of three groups. Patients from the first group (n = 123) were recruited from the Cleft Lip and Palate Team of the University Hospitals Leuven (CLPT-UHL). The second group (n = 81) consisted of patients consulting the Cleft Lip and Palate Team of the Radboud University Medical Centre Nijmegen (CLPT-UMCN). Healthy non-cleft lip and/or palate patients (n = 100) recruited from a private orthodontic practice were enrolled in group 3. All maxillary premolars were examined. RESULTS Out of the total sample, 43 patients showed developmental defects on one or more premolars. All defects occurred in patients of group 1 who received surgical closure by the CLPT-UHL. None of the patients from group 2 and 3 showed defects. CONCLUSIONS It can be suggested that the surgical technique, used by the CLPT-UHL for soft palate closure, causes these defects. It is postulated that the technique used by the CLPT-UHL leads to interference with the blood supply of the developing premolar at a critical stage of tooth enamel development. More research is needed to confirm these findings.
Collapse
Affiliation(s)
- S Carpentier
- Department of Oral Health Sciences-Orthodontics, Katholieke Universiteit Leuven and Dentistry, University Hospitals Leuven, Kapucijnenvoer 7, 3000, Leuven, Belgium
| | | | | | | | | |
Collapse
|
22
|
Lamalle P, Beaumont B, Kazarian F, Gassmann T, Agarici G, Ajesh P, Alonzo T, Arambhadiya B, Argouarch A, Bamber R, Berger-By G, Bernard JM, Brun C, Carpentier S, Clairet F, Colas L, Courtois X, Davis A, Dechelle C, Doceul L, Dumortier P, Durodié F, Ferlay F, Firdaouss M, Fredd E, Giacalone JC, Goulding R, Greenough N, Grine D, Hancock D, Hari J, Hillairet J, Hosea J, Huygen S, Jacquinot J, Jacquot J, Kaye A, Keller D, Kyrytsya V, Lockley D, Louche F, Machchhar H, Manon E, Mantel N, Martin R, McCarthy M, Messiaen A, Meunier L, Milanesio D, Missirlian M, Mohan K, Mukherjee A, Nightingale M, Patadia D, Patel A, Perrollaz G, Peters B, Pitts R, Porton M, Rajnish K, Rasmussen D, Rathi D, Sanabria R, Sartori R, Shannon M, Simonetto A, Singh R, Suthar G, Swain D, Thomas P, Tigwell P, Trivedi R, Vervier M, Vrancken M, Wilson D, Winkler K. Status of the ITER Ion Cyclotron H&CD system. Fusion Engineering and Design 2013. [DOI: 10.1016/j.fusengdes.2012.11.027] [Citation(s) in RCA: 28] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
23
|
Schoenaers J, Carpentier S, Coucke W, van Gastel J, Carels C, Verdonck A. Stability of transverse maxillary expansion after segmental posterior subapical maxillary osteotomy (SPSMO) in cleft lip and palate patients. Int J Oral Maxillofac Surg 2013. [DOI: 10.1016/j.ijom.2013.07.118] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
24
|
Carpentier S, N'Kuli F, Grieco G, Van Der Smissen P, Janssens V, Emonard H, Bilanges B, Vanhaesebroeck B, Gaide Chevronnay HP, Pierreux CE, Tyteca D, Courtoy PJ. Class III phosphoinositide 3-kinase/VPS34 and dynamin are critical for apical endocytic recycling. Traffic 2013; 14:933-48. [PMID: 23621784 DOI: 10.1111/tra.12079] [Citation(s) in RCA: 26] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/27/2012] [Revised: 04/23/2013] [Accepted: 04/26/2013] [Indexed: 12/27/2022]
Abstract
Recycling is a limiting step for receptor-mediated endocytosis. We first report three in vitro or in vivo evidences that class III PI3K/VPS34 is the key PI3K isoform regulating apical recycling. A substractive approach, comparing in Opossum Kidney (OK) cells a pan-class I/II/III PI3K inhibitor (LY294002) with a class I/II PI3K inhibitor (ZSTK474), suggested that class III PI3K/VPS34 inhibition induced selective apical endosome swelling and sequestration of the endocytic receptor, megalin/LRP-2, causing surface down-regulation. GFP-(FYVE)x2 overexpression to sequester PI(3)P caused undistinguishable apical endosome swelling. In mouse kidney proximal tubular cells, conditional Vps34 inactivation also led to vacuolation and intracellular megalin redistribution. We next report that removal of LY294002 from LY294002-treated OK cells induced a spectacular burst of recycling tubules and restoration of megalin surface pool. Acute triggering of recycling tubules revealed recruitment of dynamin-GFP and dependence of dynamin-GTPase, guidance directionality by microtubules, and suggested that a microfilamentous net constrained endosomal swelling. We conclude that (i) besides its role in endosome fusion, PI3K-III is essential for endosome fission/recycling; and (ii) besides its role in endocytic entry, dynamin also supports tubulation of recycling endosomes. The unleashing of recycling upon acute reversal of PI3K inhibition may help study its dynamics and associated machineries.
Collapse
Affiliation(s)
- Sarah Carpentier
- CELL Unit, Université catholique de Louvain & de Duve Institute, Brussels, Belgium
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
25
|
Carpentier S, Royer B, Leroy F, Maaloul F. Development of an innovative approach to predict and reduce the patient radiation dose risk in interventional cardiology. Phys Med 2013. [DOI: 10.1016/j.ejmp.2013.08.047] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/26/2022] Open
|
26
|
Tarrerias AL, Costil V, Vicari F, Létard JC, Adenis-Lamarre P, Aisène A, Batistelli D, Bonnaud G, Carpentier S, Dalbiès P, Ecuer S, Etienne J, Fantoli M, Grunberg B, Lannoy P, Lapuelle J, Margulies A, Neumeier M, Rouillon JM, Schmets L, Pingannaud MP, Coulom P, Kholer F, Canard JM. The effect of inactivated Lactobacillus LB fermented culture medium on symptom severity: observational investigation in 297 patients with diarrhea-predominant irritable bowel syndrome. Dig Dis 2011; 29:588-91. [PMID: 22179215 DOI: 10.1159/000332987] [Citation(s) in RCA: 26] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/02/2023]
Abstract
INTRODUCTION Little is known about the intensity of symptoms of diarrhea-predominant IBS (IBS-D) or the consequences of the disease on patients' health-related quality of life (HRQOL). This observational investigation assessed the symptoms (abdominal pain, bloating, number of stools per day, and stool consistency), impact on HRQOL, and consequence on anal continence in 297 patients with IBS-D before and after 1 month of probiotic treatment with Lacteol (inactivated Lactobacillus LB plus fermented culture medium). METHODS Functional assessment using a standardized visual analogue scale in order to quantify abdominal pain, bloating, and quality of life before and after 1 month of treatment with 2 capsules/day of Lacteol. The number of symptomatic days per week, number of stools, consistency of stools, secondary fecal incontinence rate, and potential trigger effect of food were quantified. A χ2 test was used to compare qualitative data and the variance of quantitative criteria was analyzed. RESULTS The pain score decreased from 4.46±0.15 on a scale of 0-10 before treatment to 2.8±0.14 after treatment (p<0.0001). Bloating decreased from 4.49±0.18 to 2.5±0.15 on a scale of 0-10 (p<0.0001). The HRQOL score, which is inversely correlated with quality of life, decreased from 5.99±0.14 to 3.92±0.16 (p<0.0001). In this cohort study, the fecal incontinence rate secondary to diarrhea was clearly higher than that of the general population: 18% versus a prevalence of 9-10%, according to different studies. The mean number of stools per week decreased from 17.59 to 12.83 after treatment (p<0.0001). Before treatment, 54% of patients had watery stools and 46% had smooth stools; at the end of treatment, only 18.5% of patients still had watery stools, and 34% had normal stools. 52% of patients attributed their symptoms to their diet: 34% to vegetables, 29% to fruit, 15% to milk, 15% to fat, 6% to peppers and spices, and 4% to sugar. CONCLUSION This observational investigation shed new light on patients with IBS-D, the HRQOL of which is altered by a fecal incontinence rate twice as high as that of the general population. Correlation with diet is confirmed by 1 out of 2 patients reporting poor tolerance of fiber and dairy products. Nutritional management should thus be part of these patients' treatment. Inactivated Lactobacillus LB plus fermented culture medium is a probiotic drug that has been used by physicians for a long time to treat patients with diarrhea. Strongly concentrated, it has no side effects and seems to help these patients. Due to a strong placebo effect in patients with this pathology, however, a controlled study is necessary to confirm this result.
Collapse
Affiliation(s)
- A L Tarrerias
- Hôpital Foch, 40, rue Worth, FR–92151 Suresnes, France.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
27
|
Azambre B, Zenboury L, Da Costa P, Capela S, Carpentier S, Westermann A. Palladium catalysts supported on sulfated ceria–zirconia for the selective catalytic reduction of NOx by methane: Catalytic performances and nature of active Pd species. Catal Today 2011. [DOI: 10.1016/j.cattod.2010.12.026] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
28
|
Reyal F, Bollet M, Caly M, Hajage D, Carpentier S, Peyro-Saint-Paul H, Pierga JY, Sigal-Zafrani B, Vincent-Salomon A, Sastre X. Abstract P3-10-09: Genomic Grade Index (GGI): Tumor Grading Performance and Prognostic Value Compared to Ki67 and Mitotic Index in Early Invasive Breast Cancer — A Reference Centre Experience. Cancer Res 2010. [DOI: 10.1158/0008-5472.sabcs10-p3-10-09] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background: Genomic grading represents a molecular approach to tumor grading. The GGI is a 97-gene assay which improves tumor grading by resolving histological grade (HG) 2 into high or low genomic grade. GGI carries added clinical value particularly in ER+/HER2-/N0 tumors where grade is a key decision factor for adjuvant treatment. The GGI algorithm has been validated for use in routine practice, including the definition of an appropriate cut-off and statistical confidence interval corresponding to a 3:1 odds-ratio. This study aimed at retrospectively testing the GGI classification performance and prognostic value in a series of 169 early breast cancers from a comprehensive cancer centre. Methods: Female breast cancers from the Institut Curie Database were selected on the following criteria: small size (pT1-2), node negative (pN0), 10-year follow-up data, availability of extracted RNA and frozen tissue. Genomic profiles were obtained using Affymetrix HGU133 Plus 2.0 gene chips. GGI was computed using Ipsogen MapQuant Dx®. Elston-Ellis (EE) grade, mitotic index (MI, mitosis/mm2), and Ki-67 IHC (continuous -% of positive cells-, or binary-median=20%-) were assessed retrospectively on the most representative tumor block in routine conditions by several pathologists. The GGI, pathological features, and proliferation markers were correlated. Survival analyses were performed using Kaplan-Meier, with comparisons using the logrank test and hazard ratios estimated using Cox proportional hazard model. Results: Profiles were obtained in 163 cases (96%).Tumor size ranged from 7 to 45 mm. 86% of tumors were ER+, and 94% were HER2-, 32.5% were EE-1, 43% EE-2 (76% mitotic score 1 and 24% mitotic score 2-3), 24.5% EE-3. Chemotherapy was given to 11 patients. Median follow-up was 12.9 yrs [0.5-15.2 yrs]. GGI classified 79% of all cases with a 95 % concordance with HG1 and HG3, and reclassified 69% of HG2 tumors (50% GGI-1 and 19% GGI-3). Concordance was 81% between Ki67 and GGI. In the ER+/HER2-/no chemotherapy subgroup (n=126), using GGI and Ki67 as continuous variables, GGI was the only significant factor in multivariate Cox regression including EE, age and size (GGI: HR=2.36 and p=0.005; Ki67: HR=1.02 and p=0.11). This was also true when GGI and Ki67 were analyzed as binary indexes (GGI: HR=5.23, p=0.02; Ki67: HR=2.44 and p=0.13). Relative risk (RR) were 4, 2.55 and 2.85 for GGI, Ki67 and MI resp. (p=0.007, p=0.052 and p=0.053). In the ER+/HG2 cohort (n=63, 10 metastasis events), RR were 3.27 and 1.78 for GGI and Ki67, none reaching statistical significance, certainly due to insufficient statistical power issue. Conclusion: In a cohort of pT1-2, pN0 early invasive breast cancers, GGI has a 95% concordance with EE grading (1 and 3) and reclassifies 69% of EE-2 tumors. In ER+/pN0/HER2- breast cancer, GGI, either continuous or binary, has a higher prognostic value than Ki67 or MI. In a reference comprehensive cancer centre setting, GGI should add clinical information in this particular breast cancer subgroup where adjuvant treatment decision remains a routine challenge.
GGI and EE tumor grading: contingency table
Citation Information: Cancer Res 2010;70(24 Suppl):Abstract nr P3-10-09.
Collapse
Affiliation(s)
- F Reyal
- Institut Curie, Paris, France; Ipsogen, Marseille, France
| | - M Bollet
- Institut Curie, Paris, France; Ipsogen, Marseille, France
| | - M Caly
- Institut Curie, Paris, France; Ipsogen, Marseille, France
| | - D Hajage
- Institut Curie, Paris, France; Ipsogen, Marseille, France
| | - S Carpentier
- Institut Curie, Paris, France; Ipsogen, Marseille, France
| | | | - J-Y Pierga
- Institut Curie, Paris, France; Ipsogen, Marseille, France
| | | | | | - X. Sastre
- Institut Curie, Paris, France; Ipsogen, Marseille, France
| |
Collapse
|
29
|
Reyal F, Bollet M, Caly M, Hajage D, Carpentier S, Peyro-Saint-Paul H, Pierga JY, Sigal-Zafrani B, Vincent-Salomon A, Sastre X. Abstract P5-13-11: Medico-Economic Assessment of the Genomic Grade Index on Adjuvant Treatment Strategy in Elston-Ellis Grade 2, Estrogen Receptor Positive, HER2 Negative, Node Negative, Small Size Breast Carcinomas. Cancer Res 2010. [DOI: 10.1158/0008-5472.sabcs10-p5-13-11] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background: Elston-Ellis grading (EE) is one of the key criteria for adjuvant therapy decision in ER+/HER2-/pN0/pT1 -2 tumors. The genomic grade index (GGI) is a 97-gene micro-array assay able to identify tumors of high or low genomic grade. GGI has been developed in order to improve the prognosis determination, especially in EE2 tumors which represent a significant proportion of breast carcinomas and where the inter-assessor variability is the highest. The aim of the present study was to model the influence of the GGI on adjuvant treatment decision in EE2 patients, using a cohort of ER+/HER2-/pN0/pT1-2 tumors.
Methods: A randomly selected series of pT1-2, pN0 breast cancers from the Institut Curie 1995-1996 cohort was profiled using Affymetrix HGU133 Plus 2.0 gene chips. The GGI was calculated using Ipsogen Mapßuant Dx®. Treatment decisions were made for EE2 cases based on the Institut Curie adjuvant treatment guidelines (www.curie.fr). The treatment decision algorithm was firstly run using the grade as defined by Elston Ellis, and secondly using the GGI (undetermined cases were classified as grade2).
Results: Out of 72 EE2 tumors, 35 were classified as GGI-1 (49%) and 13 (18%) as GGI-3. Based on EE, 7% of patients would have received adjuvant chemotherapy (ACT) alone (all were ER-/PR-), 50% adjuvant hormonal therapy (AHT) alone, and 43% both. Using the GGI, 7% (n=5) of patients would have been spared AHT and 10% (n=7) ACT. In the ER+/HER2- subgroup of 62 pts, 58% of patients would have received AHT alone and 42% AHT+ACT based on EE; GGI would have lead to a 14% reduction in AHT prescription and to a 26% reduction in ACT prescription. Conclusion: Applying the Genomic Grade Index instead of the Elston Ellis Grade to determine the adjuvant treatment strategy in a series of EE2/ER+/HER2-/pN0/pT1-2 breast carcinomas would lead to a 14% and 27% reduction in the administration of, respectively, adjuvant hormone-therapy and chemotherapy.
Adjuvant treatment decision: models based on Elston-Ellis or Genomic Grading
Citation Information: Cancer Res 2010;70(24 Suppl):Abstract nr P5-13-11.
Collapse
Affiliation(s)
- F Reyal
- Institut Curie, Paris, France; Institut Curie, France; Ipsogen, Marseille, France
| | - M Bollet
- Institut Curie, Paris, France; Institut Curie, France; Ipsogen, Marseille, France
| | - M Caly
- Institut Curie, Paris, France; Institut Curie, France; Ipsogen, Marseille, France
| | - D Hajage
- Institut Curie, Paris, France; Institut Curie, France; Ipsogen, Marseille, France
| | - S Carpentier
- Institut Curie, Paris, France; Institut Curie, France; Ipsogen, Marseille, France
| | - H Peyro-Saint-Paul
- Institut Curie, Paris, France; Institut Curie, France; Ipsogen, Marseille, France
| | - J-Y Pierga
- Institut Curie, Paris, France; Institut Curie, France; Ipsogen, Marseille, France
| | - B Sigal-Zafrani
- Institut Curie, Paris, France; Institut Curie, France; Ipsogen, Marseille, France
| | - A Vincent-Salomon
- Institut Curie, Paris, France; Institut Curie, France; Ipsogen, Marseille, France
| | - X. Sastre
- Institut Curie, Paris, France; Institut Curie, France; Ipsogen, Marseille, France
| |
Collapse
|
30
|
Peyro-Saint-Paul H, Tagett R, Carpentier S, Catteau A. Abstract P3-10-08: Combining Genomic Grade and NPI Refines Risk Group Classification. Cancer Res 2010. [DOI: 10.1158/0008-5472.sabcs10-p3-10-08] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background: The Nottingham Prognostic Index (NPI) is a clinically validated prognostic model which predicts survival for patients with early primary breast cancer. The NPI combines information on tumor size, lymph node stage and tumor grade and stratifies patients into risk groups useful for treatment decisions. Classically, NPI defines 5 risk categories: Excellent, Good, Moderate I, Moderate II and Poor Prognostic Group (EPG, GPG, MPGI, MPGII and PPG). However, the value of NPI to identify EPG patients has recently being challenged. The Genomic Grade Index (GGI) is a 97-gene test which has been shown to improve tumor grading by resolving the intermediate Histological Grade (HG) 2 tumors into high or low Genomic Grades. In this study, we investigated the potential of GGI to refine the NPI classification, and especially to discriminate patients with the lowest risk.
Material and methods:Breast cancer microarray profiles from node negative, untreated patients with the required clinical and pathological information were retrieved from 3 public databases. GGI was calculated using the Ipsogen MapQuant Dx® protocol which defines two classes, GG1 and GG3 (results falling in the CI are reported as Undetermined, “UD”). Standard NPI was calculated based on HG according to the usual formula: [0.2 x tumor size (cm) + HG(1-3) + LN stage (I-III)]. NPI scores were also calculated using GGI (“G-NPI”): the HG was replaced by the GG in the equation, and UD patients were given a value of 2 for tumor grade. Patients were classified into prognostic groups (cut-offs 2.4, 3.4 and 5.4) for both NPI (EPG, GPG, MPG and PPG) and G-NPI (G-EPG, G-GPG, G-MPG and G-PPG). NPI and G-NPI risk classifications were compared and prognostic performances were analyzed using Kaplan Meier survival curves (10-yr MFS).
Results:Unique microarray expression profiles with adequate MapQuant Dx® quality criteria and relevant clinical information were identified for 472 patients. HG was distributed as follows: 18 % HG1, 52 % HG2 and 30% HG3 with size ranging from 0.1 to 6 cm (mean = 2.1 cm). HG2 cases (n=246) were reclassified into 47% GG1 and 28% GG3, with 25% remaining UD. There were no patients classified in the PPG, using the standard NPI or the G-NPI. Comparison of risk group classification showed that G-NPI globally shifted patients from low to better prognostic groups: 28% of patients were classified in the G-EPG as opposed to only 12% in the EPG [Table 1]. Within the HG2 subgroup, none of the patients were classified in the EPG by standard NPI, while 75 patients were classified in this group by G-NPI. In the entire cohort, EPG and G-EPG 10-yrs MFS were comparable (82 and 88% resp.). In the HG2 subgroup, 10-yrs MFS was 92% for the G-EPG, 87 % for the G-GPG and 57% for the G-MPG.
Conclusion: Using GGI to calculate NPI scores provides additional information compared to standard NPI. This is particularly true in the HG2 group where G-NPI is able to identify patients matching the EPG definition with a 92% 10-yr MFS. Combining genomic information with NPI may facilitate adjuvant therapy decision making. This approach deserves further validation.
Prognostic Group Classification according to classic NPI and G-NPI
Citation Information: Cancer Res 2010;70(24 Suppl):Abstract nr P3-10-08.
Collapse
Affiliation(s)
| | - R Tagett
- Ipsogen, Marseille, France; Ipsogen, France
| | | | - A. Catteau
- Ipsogen, Marseille, France; Ipsogen, France
| |
Collapse
|
31
|
Dorn C, Green AG, Jongens R, Carpentier S, Kaiser AE, Campbell F, Horstmeyer H, Campbell J, Finnemore M, Pettinga J. High-resolution seismic images of potentially seismogenic structures beneath the northwest Canterbury Plains, New Zealand. ACTA ACUST UNITED AC 2010. [DOI: 10.1029/2010jb007459] [Citation(s) in RCA: 31] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
|
32
|
Miranda L, Carpentier S, Platek A, Hussain N, Gueuning MA, Vertommen D, Ozkan Y, Sid B, Hue L, Courtoy PJ, Rider MH, Horman S. AMP-activated protein kinase induces actin cytoskeleton reorganization in epithelial cells. Biochem Biophys Res Commun 2010; 396:656-61. [PMID: 20438708 DOI: 10.1016/j.bbrc.2010.04.151] [Citation(s) in RCA: 50] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/26/2010] [Accepted: 04/27/2010] [Indexed: 12/13/2022]
Abstract
AMP-activated protein kinase (AMPK), a known regulator of cellular and systemic energy balance, is now recognized to control cell division, cell polarity and cell migration, all of which depend on the actin cytoskeleton. Here we report the effects of A769662, a pharmacological activator of AMPK, on cytoskeletal organization and signalling in epithelial Madin-Darby canine kidney (MDCK) cells. We show that AMPK activation induced shortening or radiation of stress fibers, uncoupling from paxillin and predominance of cortical F-actin. In parallel, Rho-kinase downstream targets, namely myosin regulatory light chain and cofilin, were phosphorylated. These effects resembled the morphological changes in MDCK cells exposed to hyperosmotic shock, which led to Ca(2+)-dependent AMPK activation via calmodulin-dependent protein kinase kinase-beta(CaMKKbeta), a known upstream kinase of AMPK. Indeed, hypertonicity-induced AMPK activation was markedly reduced by the STO-609 CaMKKbeta inhibitor, as was the increase in MLC and cofilin phosphorylation. We suggest that AMPK links osmotic stress to the reorganization of the actin cytoskeleton.
Collapse
Affiliation(s)
- Lisa Miranda
- de Duve Institute, Université catholique de Louvain, Avenue Hippocrate, B-1200 Brussels, Belgium
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
33
|
Tyteca D, D'Auria L, Der Smissen PV, Medts T, Carpentier S, Monbaliu J, de Diesbach P, Courtoy P. Three unrelated sphingomyelin analogs spontaneously cluster into plasma membrane micrometric domains. Biochimica et Biophysica Acta (BBA) - Biomembranes 2010; 1798:909-27. [DOI: 10.1016/j.bbamem.2010.01.021] [Citation(s) in RCA: 35] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/21/2009] [Revised: 01/22/2010] [Accepted: 01/27/2010] [Indexed: 01/01/2023]
|
34
|
Lafont E, Milhas D, Carpentier S, Garcia V, Jin ZX, Umehara H, Okazaki T, Schulze-Osthoff K, Levade T, Benoist H, Ségui B. Caspase-mediated inhibition of sphingomyelin synthesis is involved in FasL-triggered cell death. Cell Death Differ 2009; 17:642-54. [DOI: 10.1038/cdd.2009.130] [Citation(s) in RCA: 41] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022] Open
|
35
|
Charpin C, Giusiano S, Charfi S, Secq V, Carpentier S, Andrac L, Lavaut MN, Allasia C, Bonnier P, Garcia S. Quantitative immunohistochemical expression of c Kit in breast carcinomas is predictive of patients' outcome. Br J Cancer 2009; 101:48-54. [PMID: 19513067 PMCID: PMC2713691 DOI: 10.1038/sj.bjc.6605113] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/23/2023] Open
Abstract
Background: c Kit (CD117) expression in tissues has been reported as a relevant target for specific therapy in some human malignancies, but has been poorly documented in breast carcinomas Methods: The prognostic significance of c Kit in a series of 924 breast carcinomas (mean follow-up, 79 months) was investigated using standardised high-throughput quantitative densitometry of immunohistochemical precipitates in tissue microarrays. Results: c Kit was expressed in 14.7% breast carcinomas (and in 42 out of 586 node-negative tumours). In univariate analysis, (log-rank test) the score of c Kit expression correlated with poor patient outcome P=0.02 and particularly in node-negative cases (P=0.002). In multivariate Cox analysis, c Kit was an indicator of metastasis independent of 25 other concomitantly evaluated markers of prognosis. Logistic regression showed that c Kit ranked 10 out of 25 (P=0.041), and was included in a 10-marker signature that allowed 79.2% of the patients to be correctly classified in the metastatic or metastasis-free categories independently of hormone receptors and HER-2 status. Interestingly, c Kit was also a significant predictor of metastasis in node-negative tumours (2 out of 25 ranking, P<0.0001) and included in a six-marker signature of prognosis, correctly classifying 88.6% of the patients (P<0.0001). Conclusion: We concluded that, as assessed by quantitative immunohistochemistry, c Kit is an independent prognostic indicator that could also potentially serve as a target for specific therapy in breast carcinomas.
Collapse
Affiliation(s)
- C Charpin
- Department of Pathology, Hôpital Nord and Université de la Méditerranée (Aix Marseille II), Marseille, France.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
36
|
Carpentier S, Bertucci F, Tagett R, Finetti P, Jacquemier J, Le Doussal JM, Hermitte F. A single genomic HER2 assay for the protein expression and the DNA amplification status. J Clin Oncol 2009. [DOI: 10.1200/jco.2009.27.15_suppl.e22082] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
e22082 Background: Currently, up to 20% of HER2 tests in breast cancer may be inaccurate. To address this situation, the 2007 ASCO/CAP guideline for HER2 testing recommended using standardized IHC (for HER2 protein expression) and FISH (for HER2 DNA amplification) in a sequential testing algorithm. However, test standardization and equivocal results still remain an issue potentially leading to inappropriate treatment decisions. A new genomic HER2 (gHER2) assay was designed to address these issues. Methods: Frozen samples of 152 primary breast cancers with a positive or negative IHC result (126 IHC 0+ and 26 IHC 3+ determined by tissue microarray) were profiled using Affymetrix U133 Plus 2.0 gene chips. Recursive feature elimination algorithm by support vector machines (RFE-SVM) was used to select probesets correlated to IHC status; to compute a genomic HER2 (gHER2) expression index; and to set a threshold discriminating between IHC 0+ from IHC 3+ samples. This gHER2 assay was validated in 4 independent datasets (n=309) and tested for its ability to reclassify HER2 equivocal cases (IHC 2+, n=21). The assay was standardized using Ipsogen MapQuant Dx. Results: RFE-SVM identified 6 known and 1 unknown genes correlating with the IHC status, all located within the HER2 DNA amplicon. The gHER2 assay gave unequivoqual HER2 status in 96.2 % of samples. The genomic HER2 assay was concordant with IHC status in 94.5% of cases. 95 % of samples with equivocal IHC status (IHC 2+) could be re-classified in accordance with FISH status in 95 % of cases. Conclusions: We could identify a genomic signature of both HER2 DNA amplification and HER2 protein expression. A new standardized genomic HER2 assay was derived that matches the ASCO/CAP guideline requirements of 95 % concordance with validated techniques. It may contribute to reduce the number of equivocal results. [Table: see text]
Collapse
Affiliation(s)
- S. Carpentier
- Ipsogen‘, Marseille, France; Institut Paoli Calmettes, Marseille, France; Ipsogen, Marseille, France
| | - F. Bertucci
- Ipsogen‘, Marseille, France; Institut Paoli Calmettes, Marseille, France; Ipsogen, Marseille, France
| | - R. Tagett
- Ipsogen‘, Marseille, France; Institut Paoli Calmettes, Marseille, France; Ipsogen, Marseille, France
| | - P. Finetti
- Ipsogen‘, Marseille, France; Institut Paoli Calmettes, Marseille, France; Ipsogen, Marseille, France
| | - J. Jacquemier
- Ipsogen‘, Marseille, France; Institut Paoli Calmettes, Marseille, France; Ipsogen, Marseille, France
| | - J. M. Le Doussal
- Ipsogen‘, Marseille, France; Institut Paoli Calmettes, Marseille, France; Ipsogen, Marseille, France
| | - F. Hermitte
- Ipsogen‘, Marseille, France; Institut Paoli Calmettes, Marseille, France; Ipsogen, Marseille, France
| |
Collapse
|
37
|
de Diesbach P, Medts T, Carpentier S, D'Auria L, Van Der Smissen P, Platek A, Mettlen M, Caplanusi A, van den Hove MF, Tyteca D, Courtoy PJ. Differential subcellular membrane recruitment of Src may specify its downstream signalling. Exp Cell Res 2008; 314:1465-79. [DOI: 10.1016/j.yexcr.2008.01.015] [Citation(s) in RCA: 31] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/25/2007] [Revised: 12/21/2007] [Accepted: 01/14/2008] [Indexed: 12/22/2022]
|
38
|
Carpentier S, Lebeau P, Vandurne B, Gheerardyn R, Vanwijck R, Lengelé B, Willemart G, El Fouly PE. The versatility of the sub-mental flap: a case report. J Plast Reconstr Aesthet Surg 2008; 61:207-9. [PMID: 17656167 DOI: 10.1016/j.bjps.2007.05.012] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/13/2006] [Revised: 11/26/2006] [Accepted: 05/21/2007] [Indexed: 10/23/2022]
Abstract
The sub-mental flap has been used in four elderly patients (mean age: 83 years) for reconstruction of defects after oncological resection: three had basal cell carcinoma (cheek, temporal region and fronto-temporal region). One had a squamous cell carcinoma of the hard palate. We believe that the latter example is original and present it in this article. This case shows that the sub-mental flap in addition to its intrinsic qualities is a reliable flap which may be useful in difficult repairs. It can be used to repair wide palatal fistula which occurs after oncological resections.
Collapse
Affiliation(s)
- S Carpentier
- Service de chirurgie plastique, Cliniques universitaires St-Luc, Bruxelles, Belgium.
| | | | | | | | | | | | | | | |
Collapse
|
39
|
Mettlen M, Platek A, Van Der Smissen P, Carpentier S, Amyere M, Lanzetti L, de Diesbach P, Tyteca D, Courtoy PJ. Src triggers circular ruffling and macropinocytosis at the apical surface of polarized MDCK cells. Traffic 2007; 7:589-603. [PMID: 16643281 DOI: 10.1111/j.1600-0854.2006.00412.x] [Citation(s) in RCA: 75] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
Abstract
We addressed the role of Src on cortical actin dynamics and polarized endocytosis in MDCK cells harboring a thermosensitive v-src mutant. Shifting monolayers established at 40 degrees C (non-permissive temperature) to 34 degrees C (permissive temperature) rapidly reactivated v-Src kinase, but tight junctions and cell polarity resisted for >6 h. At this interval, activated v-src was recruited on apical vesicles, induced cortactin-associated apical circular ruffles productive of macropinosomes, thereby accelerating apical pinocytosis by approximately fivefold. Ruffling and macropinosome formation were selectively abrogated by inhibitors of actin polymerization, phosphoinositide 3-kinase, phospholipase C, and phospholipase D, which all returned apical pinocytosis to the level observed at 40 degrees C, underscoring the distinct control of apical micropinocytosis and macropinocytosis. Src promoted microtubule-dependent fusion of macropinosomes to the apical recycling endosome (ARE), causing its strong vacuolation. However, preservation of tubulation and apical polarity indicated that its function was not affected. The ARE was labeled for v-src, Rab11, and rabankyrin-5 but not early endosome antigen 1, thus distinguishing two separate Rab5-dependent apical pathways. The mechanisms of Src-induced apical ruffling and macropinocytosis could shed light on the triggered apical enteroinvasive pathogens entry and on the apical differentiation of osteoclasts.
Collapse
Affiliation(s)
- Marcel Mettlen
- CELL Unit, Université catholique de Louvain and Christian de Duve Institute of Cellular Pathology, 1200 Brussels, Belgium
| | | | | | | | | | | | | | | | | |
Collapse
|
40
|
Abstract
Shaken baby syndrome, a rotational acceleration injury, is most common between 3 and 6 months of age and causes death in about 10 to 40% of cases and permanent neurological abnormalities in survivors. We developed a mouse model of shaken baby syndrome to investigate the pathophysiological mechanisms underlying the brain damage. Eight-day-old mouse pups were shaken for 15 seconds on a rotating shaker. Animals were sacrificed at different ages after shaking and brains were processed for histology. In 31-day-old pups, mortality was 27%, and 75% of survivors had focal brain lesions consisting of hemorrhagic or cystic lesions of the periventricular white matter, corpus callosum, and brainstem and cerebellar white matter. Hemorrhagic lesions were evident from postnatal day 13, and cysts developed gradually between days 15 and 31. All shaken animals, with or without focal lesions, had thinning of the hemispheric white matter, which was significant on day 31 but not earlier. Fragmented DNA labeling revealed a significant increase in cell death in the periventricular white matter, on days 9 and 13. White matter damage was reduced by pre-treatment with the NMDA receptor antagonist MK-801. This study showed that shaking immature mice produced white matter injury mimicking several aspects of human shaken baby syndrome and provided evidence that excess release of glutamate plays a role in the pathophysiology of the lesions.
Collapse
Affiliation(s)
- C Bonnier
- Service de Neurologie Pédiatrique, University of Louvain Medical School, Bruxelles, Belgium
| | | | | | | | | |
Collapse
|
41
|
Granot T, Milhas D, Carpentier S, Dagan A, Ségui B, Gatt S, Levade T. Caspase-dependent and -independent cell death of Jurkat human leukemia cells induced by novel synthetic ceramide analogs. Leukemia 2006; 20:392-9. [PMID: 16397504 DOI: 10.1038/sj.leu.2404084] [Citation(s) in RCA: 32] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
Ceramide metabolism has emerged as a potential target for anticancer therapy. Here, the potential usefulness of two novel synthetic ceramide analogs as anti-leukemic drugs was investigated. Compounds AD2646 and AD2687 were able to dose-and time-dependently decrease the viability of Jurkat leukemic cells. This was accompanied by an accumulation of endogenous ceramide owing to perturbed ceramide metabolism. Cytotoxicity involved caspase activation but also necrotic-like features, as evidenced by phosphatidylserine externalization, membrane permeability, hypodiploidy, caspase processing and only partial protection from cell death by a pan-caspase inhibitor. Ceramide analogs also induced cell death in Jurkat mutants that are deficient in cell death signaling proteins, including FADD, caspase-8 and 10, and RIP. While overexpression of Bcl-xL did not suppress ceramide accumulation, it conferred robust protection from caspase activation and cell death. Altogether, these novel ceramide analogs are able to kill leukemic cells through distinct pathways implicating caspase activation and mitochondrial events, and represent a new group of bioactive molecules with potential applications in anticancer therapy.
Collapse
Affiliation(s)
- T Granot
- Department of Biochemistry, Hebrew University-Hadassah School of Medicine, Jerusalem, Israel
| | | | | | | | | | | | | |
Collapse
|
42
|
Therade-Matharan S, Laemmel E, Carpentier S, Obata Y, Levade T, Duranteau J, Vicaut E. Reactive oxygen species production by mitochondria in endothelial cells exposed to reoxygenation after hypoxia and glucose depletion is mediated by ceramide. Am J Physiol Regul Integr Comp Physiol 2005; 289:R1756-62. [PMID: 16278342 DOI: 10.1152/ajpregu.00480.2004] [Citation(s) in RCA: 36] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/10/2023]
Abstract
In endothelium, reoxygenation after hypoxia (H/R) has been shown to induce production of reactive oxygen species (ROS) by complex III of the mitochondrial respiratory chain. The purpose of the present study was to test the involvement of ceramide in this phenomenon. Human umbilical vein endothelial cells underwent 2 h of hypoxia (Po2, ∼20 mmHg) without glucose and 1 h of reoxygenation (Po2, ∼120 mmHg) with glucose. ROS production was measured by the fluorescent marker 2′,7′-dichlorodihydrofluorescein diacetate, and cell death by propidium iodide. We showed that 1) after 1 h of reoxygenation, fluorescence had risen and that ROS production was inhibited by desipramine, an inhibitor of sphingomyelinase, an enzyme responsible for ceramide production (126 ± 7% vs. 48 ± 12%, P < 0.05); 2) administration of ceramide ( N-acetylsphingosine) per se (i.e., in the absence of H/R) induced ROS production (65 ± 3%), which was inhibited by complex III inhibitor: antimycin A (24 ± 3%, P < 0.0001), or stigmatellin (31 ± 2%, P < 0.0001); 3) hypoxia/reoxygenation-induced ROS production was not affected by either ceramide-activated protein kinase inhibitor dimethyl aminopurine or mitochondrial permeability transition inhibitor cyclosporin A but was significantly inhibited by the antiapoptotic protein Bcl-2 (82 ± 8%, P < 0.05); 4) ceramide-induced ROS production was also inhibited by Bcl-2 (41 ± 4%, P < 0.0001). These results demonstrate that in endothelial cells submitted to hypoxia and glucose depletion followed by reoxygenation with glucose, the pathway implicated in mitochondrial complex III ROS production is ceramide dependent and is decreased by the antiapoptotic protein Bcl-2.
Collapse
Affiliation(s)
- S Therade-Matharan
- Laboratoire d'Etude de la Microcirculation, Faculté de Médecine, Université Paris 7 10, avenue de Verdun, 75010 Paris, France
| | | | | | | | | | | | | |
Collapse
|
43
|
Quintyn J, Carpentier S, Malecaze F, Levade T, Mathis A. 022 Étude de l’apoptose rétinienne par dosage du céramide lors d’un décollement de rétine expérimental. J Fr Ophtalmol 2005. [DOI: 10.1016/s0181-5512(05)74418-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
44
|
Carpentier S, Witters E, Laukens K, Panis B, Swennen R. Proteome analysis: a successful approach for functional research in recalcitrant non-model crops. Commun Agric Appl Biol Sci 2005; 70:3-4. [PMID: 16366263] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/05/2023]
Affiliation(s)
- S Carpentier
- Laboratory of Tropical Crop Improvement, Catholic University of Leuven, Belgium
| | | | | | | | | |
Collapse
|
45
|
Criel B, Panta A, Carpentier S, Renaut J, Swennen R, Panis B, Hausman JF. Cryopreservation and abiotic stress tolerance in potato: a proteomic approach. Commun Agric Appl Biol Sci 2005; 70:83-6. [PMID: 16366280] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/05/2023]
Affiliation(s)
- B Criel
- Laboratory of Tropical Crop Improvement, Leuven, Belgium
| | | | | | | | | | | | | |
Collapse
|
46
|
Marcy M, Tamagnini P, Iacobone M, Sebag F, Carpentier S, Dales JP, Henry JF, De Micco C. Carcinomes médullaires macroscopiques de la thyroïde : recherche de facteurs prédictifs de l’envahissement ganglionnaire. Ann Pathol 2004. [DOI: 10.1016/s0242-6498(04)94152-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
47
|
Abstract
BACKGROUND Helicobacter pylori infection increases the risk of gastric cancer but the molecular mechanisms responsible are not well understood. Gastric cells chronically exposed to H pylori in vitro develop resistance to apoptosis associated with low levels of p27, a cyclin dependent kinase inhibitor and haplo insufficient tumour suppressor gene that is downregulated in gastric cancer. AIM To determine whether the low level of p27 protein is responsible for the resistance to apoptosis of gastric cancer cells. METHODS The effects of increasing the expression of p27 protein were examined by transiently and stably transfecting a plasmid encoding full length p27 mRNA into apoptosis resistant gastric cancer cell lines with low p27 expression that were derived from AGS gastric cancer cells by chronic H pylori coculture followed by dilutional cloning. RESULTS Low p27 expression in the apoptosis resistant derivative cell lines was associated with an approximate 30% decrease in p27 mRNA and an 80% decrease in p27 protein that was not due to increased proteasome dependent degradation of p27 protein. Transient or stable transfection with p27 constructs partially restored the sensitivity of the apoptosis resistant cells to 5-fluorouracil and H pylori induced apoptosis without altering spontaneous apoptotic cell death. CONCLUSIONS These results demonstrate that p27 positively regulates, at least in part, the apoptotic response of gastric epithelial cells to H pylori. Low gastric p27 may promote gastric carcinogenesis associated with H pylori infection by inhibiting apoptotic pathways.
Collapse
Affiliation(s)
- H Eguchi
- Division of Gastroenterology, Department of Medicine, Rhode Island Hospital/Brown University, Providence, RI 02903, USA
| | | | | | | |
Collapse
|
48
|
Dales JP, Garcia S, Carpentier S, Andrac L, Ramuz O, Lavaut MN, Allasia C, Bonnier P, Taranger-Charpin C. Prediction of metastasis risk (11 year follow-up) using VEGF-R1, VEGF-R2, Tie-2/Tek and CD105 expression in breast cancer (n=905). Br J Cancer 2004; 90:1216-21. [PMID: 15026804 PMCID: PMC2409639 DOI: 10.1038/sj.bjc.6601452] [Citation(s) in RCA: 42] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022] Open
Abstract
Neoangiogenesis in tumours contributes to the development of blood-borne metastases, and can be evaluated by markers of activated endothelial cells in preference to panendothelial markers. Our purpose was to document the prognostic significance of VEGF-R1, VEGF-R2, Tie-2/Tek and CD105 immunoexpression in breast carcinoma frozen samples (n=905, follow-up=11.7 years). We observed that: (i) CD105 (P=0.001) and Tie-2/Tek (P=0.025) (but not VEGF-R1 and VEGF-R2) overexpression correlated with a shorter survival, and were (Cox's model) independent histoprognostic indicators; (ii) only CD105 marked expression correlated (P=0.035) with a shorter survival of node-negative patients; (iii) three markers – CD105 (P=0.001), Tie-2/Tek (P=0.01), VEGF-R1 (P=0.001), but not VEGF-R2 – correlated with metastatic risk in node-negative patients in univariate analysis; and (iv) VEGF-R1 (P=0.01) expression correlated with high local recurrence risk. It is concluded that CD105 and to a lesser extent Tie-2/Tek and VEGF-R1, but not VEGF-R2 are endowed with prognostic significance that may be useful for patient monitoring, particularly CD105 expression for selecting node-negative patients for more aggressive postsurgery therapy.
Collapse
Affiliation(s)
- J P Dales
- Department of Pathology, Centre Hospitalier et Universitaire Nord, Marseille Cedex 20, France
| | - S Garcia
- Department of Pathology, Centre Hospitalier et Universitaire Nord, Marseille Cedex 20, France
| | - S Carpentier
- Department of Pathology, Centre Hospitalier et Universitaire Nord, Marseille Cedex 20, France
| | - L Andrac
- Department of Pathology, Centre Hospitalier et Universitaire Nord, Marseille Cedex 20, France
| | - O Ramuz
- Department of Pathology, Centre Hospitalier et Universitaire Nord, Marseille Cedex 20, France
| | - M N Lavaut
- Department of Pathology, Centre Hospitalier et Universitaire Nord, Marseille Cedex 20, France
| | - C Allasia
- Department of Pathology, Centre Hospitalier et Universitaire Nord, Marseille Cedex 20, France
| | - P Bonnier
- Department of Gynecologic Oncology, Hôpital de La Conception, Marseille, France
| | - C Taranger-Charpin
- Department of Pathology, Centre Hospitalier et Universitaire Nord, Marseille Cedex 20, France
- Department of Pathology, Centre Hospitalier et Universitaire Nord, Marseille Cedex 20, France. E-mail:
| |
Collapse
|
49
|
Abstract
Collagenous spherulosis (CS) is an incidental finding that usually occurs in association with benign proliferative and preinvasive lesions. Adenomyoepithelioma is a biphasic neoplasm of the breast, composed of both luminal epithelial and myoepithelial cells. Despite the common epimyoepithelial histogenesis, CS has never been described in association with adenomyoepithelioma. This report describes the case of a 48 year old woman who presented with CS of the breast in an adenomyoepithelioma. The combination of these two benign lesions led to diagnostic difficulties; namely, differentiation from adenoid cystic carcinoma, but also cribriform carcinoma and cylindroma of the breast. Antibodies to the oestrogen receptor, progesterone receptor, p63, and c-kit (CD117) proved to be useful adjuncts to differentiate between these lesions.
Collapse
Affiliation(s)
- J S Reis-Filho
- The Breakthrough Toby Robins Breast Cancer Research Centre, Institute of Cancer Research, London SW3 6JB UK
| | | | | | | | | |
Collapse
|
50
|
Carpentier S, Moilleron R, Beltran C, Hervé D, Thévenot D. Quality of dredged material in the river Seine basin (France). II. Micropollutants. Sci Total Environ 2002; 299:57-72. [PMID: 12465592 DOI: 10.1016/s0048-9697(02)00278-4] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/24/2023]
Abstract
Dredging rivers is needed to ensure safe navigable waters, rivers and waterways. To anticipate the management of dredged materials in the case of the river Seine basin, the quality of the sediments in the river is checked every 3 years before dredging operations. The river Seine Basin is heavily submitted to pollution pressure from nearby industrial activities and urban expansion of Paris and its region. Here, the micropollutant content of the sediment sampled in 1996, 1999 and 2000 before dredging is discussed compared to regulatory standards. The results indicate that most of the sediment samples from the river Seine basin are lightly to moderately contaminated with organic and inorganic micropollutants (heavy metals, PAH, PCB), which makes the management after dredging easier. This pollution is strongly correlated with the organic matter content and to the fine fraction (<50 microm) of the sediment. These results can lead to other management options than the ones already used in the river Seine basin: (1) dumping of lightly to moderately polluted sediments in quarries; and (2) physical treatment (sieving, hydrocycloning) of contaminated sediments issued from 'hot spots'.
Collapse
Affiliation(s)
- S Carpentier
- Centre d'enseignement et de recherche sur l'eau la ville et l'environnement (Cereve), UMR 99022101 MENRT-MAP, Cereve, Université Paris XII-Val de Marne, 61, avenue du General de Gaulle, France.
| | | | | | | | | |
Collapse
|